arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2109.08718q-bio.MNcs.LG
收藏

可卡因成瘾的蛋白质组信息机器学习研究

Proteome-informed machine learning studies of cocaine addiction

Michigan State University(密歇根州立大学)

Kaifu Gao, Dong Chen, Alfred J Robison, Guo-Wei Wei

摘要:

可卡因成瘾占物质使用障碍的很大一部分,并威胁着全世界数百万人的生命。迫切需要开发出有效的抗可卡因成瘾药物。不幸的是,尽管在过去的几十年里做出了广泛的努力,但食品和药物管理局(FDA)还没有批准任何药物。主要的挑战是可卡因成瘾的复杂分子机制,涉及受可卡因影响的多巴胺转运蛋白(DAT)功能的上游和下游蛋白质之间的协同相互作用。然而,传统的体内或体外实验无法解决如此多的蛋白质的作用,突出了该领域创新策略的必要性。我们提出了一个蛋白质组信息的机器学习/深度学习(ML/DL)平台,以发现几乎最佳的抗可卡因成瘾先导化合物。我们构建和分析可卡因依赖的蛋白质组学蛋白质相互作用(PPI)网络,以确定141个涉及的药物靶标,并使用从超过1.04亿个分子训练的自动编码器(EA)模型在潜在空间中表示超过60,000个相关的候选药物或实验药物。我们建立了32个ML模型,用于这些候选药物的副作用和再利用潜力的交叉靶点分析。我们进一步筛选这些候选药物的吸收、分布、代谢、排泄和毒性(ADMET)特性。我们的平台显示,基本上所有现有的候选药物,包括数十种实验性药物,都未能通过我们的交叉靶点和ADMET筛选。尽管如此,我们已经确定了两个接近最佳的线索,以进一步优化。

英文摘要:

Cocaine addiction accounts for a large portion of substance use disorders and threatens millions of lives worldwide. There is an urgent need to come up with efficient anti-cocaine addiction drugs. Unfortunately, no medications have been approved by the Food and Drug Administration (FDA), despite the extensive effort in the past few decades. The main challenge is the intricate molecular mechanisms of cocaine addiction, involving synergistic interactions among proteins upstream and downstream of dopamine transporter (DAT) functions impacted by cocaine. However, traditional in vivo or in vitro experiments can not address the roles of so many proteins, highlighting the need for innovative strategies in the field. We propose a proteome-informed machine learning/deep learning (ML/DL) platform to discover nearly optimal anti-cocaine addiction lead compounds. We construct and analyze proteomic protein-protein interaction (PPI) networks for cocaine dependence to identify 141 involved drug targets and represent over 60,000 associated drug candidates or experimental drugs in the latent space using an autoencoder (EA) model trained from over 104 million molecules. We build 32 ML models for cross-target analysis of these drug candidates for side effects and repurposing potential. We further screen the absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of these candidates. Our platform reveals that essentially all of the existing drug candidates, including dozens of experimental drugs, fail to pass our cross-target and ADMET screenings. Nonetheless, we have identified two nearly optimal leads for further optimization.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑